The Effect of Mild Traumatic Brain Injury on Cerebral Microbleeds in Aging

Introduction

A traumatic brain injury (TBI) has been shown to induce the formation of cerebral microbleeds (CMBs) (Huang et al., 2015; Toth et al., 2016, 2020; Ungvari et al., 2017; Irimia et al., 2018; Griffin et al., 2019). Cerebral microbleeds are hemosiderin deposits that are 5–10 mm in diameter as a result of bleeding from injured small cerebral arteries, arterioles, or capillaries. They are also associated with the development of cognitive impairments, psychiatric disorders, and gait dysfunctions (Werring et al., 2010; de Laat et al., 2011; Wang et al., 2014, 2018; Huang et al., 2015; Toth et al., 2015, 2020; Akoudad et al., 2016; Ungvari et al., 2017, 2018; Irimia et al., 2018; Nyúl-Tóth et al., 2020). Due to orthostatic hypotension, dehydration, and impaired balance, the elderly population frequently suffers TBIs (Krishnamoorthy et al., 2015; Irimia et al., 2018; Rauen et al., 2020). The most common form of TBI affecting elderly people is mild brain trauma (mTBI) (Rachmany et al., 2013; Krishnamoorthy et al., 2015; Rauen et al., 2020). Similar to TBI, aging is also an independent risk factor for the development of CMBs (Toth et al., 2015, 2020; Ungvari et al., 2017; Irimia et al., 2018). The number of CMBs increases with age, and they are causally linked to age-related cognitive decline and gait disturbances. Interestingly, mechanisms leading to the formation of CMBs, such as cerebrovascular oxidative stress, the activation of matrix metalloproteinases, and the modification of the content of the cerebrovascular wall, are all induced by both aging and TBIs (Lewén et al., 2001; Werring et al., 2010; Rachmany et al., 2013; Abdul-Muneer et al., 2016; Ungvari et al., 2017, 2018; Griffin et al., 2019; Go et al., 2020). However, it is not well established and characterized how TBIs and aging interact to promote the development of CMBs, especially after an mTBI. In this brief study, we tested the hypothesis that an mTBI exacerbates the development of CMBs in the elderly compared with young patients, and aimed to characterize the location and distribution of CMBs in elderly patients after an mTBI.

Materials and Methods

Study Population

The study was approved by the Regional Ethic Committee of the University of Pecs, Medical School, Hungary (7270-PTE 2018). We retrospectively analyzed the medical history and three Tesla susceptibility weighted (SWI) MRIs of 35 patients (15 males and 20 females) who had suffered mTBIs [Glasgow Coma Scale (GCS) 14–15] and were admitted to the Department of Neurosurgery, Medical School, University of Pecs, Hungary between April of 2014 and September of 2019. We also analyzed the SWI MRI images of 43 aged-matched control patients (17 males and 26 females) without a medical history of a TBI. For the TBI groups, the inclusion criteria were: young, age is between 18 and 40 years; aged, above 60 years old at the time of the injury; an mTBI in the history within 6 months of the MRI; an mTBI according to Mayo criteria: GCS 14–15, absence or a maximum of 30 min of loss of consciousness, and the absence of post-traumatic amnesia (PTA) (Malec et al., 2007). Exclusion criteria: any conditions associated with CMB formation in the medical history, such as epilepsy, a previous TBI, stroke, transient ischemic attack, cavernous malformations, cerebral amyloid angiopathy, chronic hypertensive encephalopathy, acute haemorrhagic leukoencephalitis, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), Alzheimer’s disease, cerebral vasculitis, cerebral metastases, haemorrhagic micrometastases, intracranial embolism, intravascular lymphoma, posterior reversible encephalopathy syndrome (PRES), progressive facial haemiatrophy, thrombotic microangiopathies, intracranial infection, and COL4A1 brain small-vessel disease (Greenberg et al., 2009; Yakushiji, 2015; Ungvari et al., 2017). For the control group, an additional exclusion criterion was a TBI in the medical records. Both in the TBI and control groups, two age groups were defined in a 2 × 2 study design: young (Y): n = 20, 10 females, 10 males, age: 25 ± 6 years; young + mTBI (Y + mTBI): n = 17, 11 females, 6 males, age: 25 ± 10 years; aged (A): n = 23, 16 females, 7 males, age: 68 ± 5 years; aged + mTBI (A + mTBI): n = 17, 9 females, 8 males, age: 72 ± 7 years.

Imaging Protocol

A brain MRI was performed using 3T (Magnetom Trio/Prismafit) Siemens MR scanners (Siemens, Munich, Germany). Susceptibility- and T1-weighted magnetization-prepared rapid acquisition with gradient echo (MPRAGE) and fluid-attenuated inversion recovery (FLAIR) images were obtained. The T1-weighted high-resolution images were then obtained using a three-dimensional (3D) MP-RAGE sequence [TI = 900–1,100 ms; TR = 1,900–2,530 ms; TE = 2.5–2.4 ms; slice thickness = 0.9–1 mm; field of view (FOV) = 256 mm × 256 mm; matrix size = 256 × 256], while 3D SWI images were acquired as follows: TR = 27–49 ms; TE = 20–40 ms; slice thickness = 1.2–3 mm; FOV = 137–201 mm × 230–240 mm; matrix size = 125–182 × 256–320, with no inter-slice gap. For image evaluation, the 3D Slicer 4.8.1¹ software was used.

Microbleed Analysis

Three independent neuroradiologists evaluated the images individually, blinded to medical history. In order to precisely identify CMBs, the exclusion of SWI lesions that mimic CMBs (intersection of veins, bottom of sulci, calcium deposits, artifacts caused by air-tissue interfaces, or macroscopic bleeding caused by, e.g., an intraventricular drain) was carried out (Greenberg et al., 2009; Yakushiji, 2015). The number and location of CMBs were obtained according to the clinically validated Microbleed Anatomic Rating Scale (MARS) (Gregoire et al., 2009). This scale distinguishes the number of definite and possible lesions and precisely localizes the CMBs according to anatomic regions as follows: (1) infratentorial: brainstem or cerebellum; (2) deep: basal ganglia, thalamus, internal or external capsule, corpus callosum, or either the periventricular or deep white matter; (3) lobar: cortex or subcortical white matter. In this study, we present only the definite lesions (Figure 1).

FIGURE 1

Figure 1. Axial susceptibility weighted (SWI) MRI (three Tesla) of a young control patient (Y, 38-year-old, male), a young patient following mild traumatic brain injury (Y + mTBI, 36-year-old male, GCS: 15), an aged control patient (A, 67-year-old male), and an aged patient with a mild TBI (A + mTBI, 65-year-old male, GCS: 15). Cerebral microbleeds (CMBs) appear as ovoid, hypointense lesions and are indicated by the red squares (R, right; L, left).

Statistical Analysis

A Kolmogorov–Smirnov test was performed to determine whether the sample data have the characteristics of a normal distribution. In order to compare the presence of microbleeds, the number of lesions, and specific distribution in different sample groups, Kruskal–Wallis with post hoc Dunn’s multiple comparison tests and Mann–Whitney U tests were performed. To evaluate the effect of comorbidities on the number of CMBs, Fisher’s exact tests were performed. Differences were considered significant at p < 0.05. Statistical analysis was performed using the Origin Pro 2018 software.

Results

The Effect of Mild Traumatic Brain Injury on the Formation of Cerebral Microbleeds in Aging

The characteristics of the patients in each group are shown in Table 1. There were no differences in the assessed cerebrovascular risk factors between the groups.

TABLE 1

Table 1. General description and main cardiovascular comorbidities of the study groups.

We found that aging exacerbated the formation of CMBs significantly (p < 0.05) compared with young patients (Figure 2A), confirming the results of previous studies showing that aging is an independent risk factor for the development of CMBs (Greenberg et al., 2009; Toth et al., 2015; Irimia et al., 2018). Importantly, the number of CMBs in elderly patients was not further increased by mTBIs (Figure 2A). An mTBI did not enhance the number of CMBs in young patients either (Figure 2A). We found that aging also significantly exacerbated (p < 0.05) the incidence of patients with CMBs regardless of the number of bleedings (percent of patients with CMBs in the given group of patients) compared with the young patients (Figure 2B), who were not affected by mTBIs (Figure 2B).

FIGURE 2

Figure 2. Effect of mild traumatic brain injury on the development and characteristics of cerebral microbleeds in the elderly. (A) Mean number of CMBs in young control (Y) patients (n = 20, age: 25.09 ± 5.63 years), young patients after an mBTI (Y + mTBI) (n = 17, age: 24.65 ± 10.22 years), aged control patients (A) (n = 23, age: 68.36 ± 4.88 years), and aged patients with mTBIs (A + mTBI, n = 17, age: 71.86 ± 7.31 years). Data are mean ± SEM, ^∗P < 0.05 vs. YC, ns: non-significant. (B) Number of patients with CMBs in the studied groups is expressed as the percent of the total number of patients in each group [young control (Y) patients (n = 20, age: 25.09 ± 5.63 years), young patients after mBTIs (Y + mTBI) (n = 17, age: 24.65 ± 10.22 years), aged control patients (A) (n = 23, age: 68.36 ± 4.88), and aged patients with mTBIs (A + mTBI) (n = 17, age: 71.86 ± 7.31 years)]. ^∗P < 0.05 vs. YC. Panel (C) depicts the localization of CMBs in each group as number of lobar, deep-seated (basal ganglion), and infratentorial CMBs expressed as the percent (%) of the total number of CMBs. Note that the majority of CMBs can be found supratentorially (lobar and basal ganglion); however, a small number of microbleeds appear in the infratentorial location in aged patients after an mTBI. The difference did not reach statistical significance. (D) Lobar distribution of supratentorial CMBs in each studied group of patients (frontal, temporal, parietal, and occipital). Please note that aging enhances the number of parietal and occipital CMBs after an mTBI (P < 0.05 vs. Y + mTBI), and that an mTBI leads to the formation of more CMBs in the frontal, parietal, and occipital lobes in aging (P < 0.05 vs. A). (Y): n = 20, 10 females, 10 males, age: 25.09 ± 5.63 years; young + mTBI (Y + mTBI): n = 17, 11 females, 6 males, age: 24.65 ± 10.22 years; aged (A): n = 23, 16 females, 7 males, age: 68.36 ± 4.88 years; aged + mTBI (A + mTBI): n = 17, 9 females, 8 males, age: 71.86 ± 7.31 years.

Location Characteristics of Aging and Mild Traumatic Brain Injury-Induced Cerebral Microbleeds

We found the majority of CMBs in the supratentorial compartment (lobar and basal ganglion); however, a small number of microbleeds appear in the infratentorial location in aged patients after an mTBI. The difference did not reach statistical significance (Figure 2C). Analysing the distribution of supratentorial CMBs across cerebral lobes (frontal, temporal, parietal, and occipital), we found that aging enhances the number of parietal and occipital CMBs after an mTBI (P < 0.05 vs. Y + mTBI), and that an mTBI leads to the formation of more CMBs in the parietal lobes in aging (P < 0.05 vs. A; Figure 2D).

Discussion

It has been shown previously that both TBIs and aging induce the development of CMBs (Huang et al., 2015; Toth et al., 2015; Ungvari et al., 2017; Irimia et al., 2018; Wang et al., 2018; Griffin et al., 2019). In both cases, CMBs are associated with long-term cognitive deficits and gait dysfunctions and determine the outcome of patients (Werring et al., 2010; de Laat et al., 2011; Huang et al., 2015; Toth et al., 2015, 2020; Yakushiji, 2015; Akoudad et al., 2016; Ungvari et al., 2017, 2018; Irimia et al., 2018; Nyúl-Tóth et al., 2020). Previous epidemiological studies have proposed that the TBI-related development of CMBs is exacerbated in aging (Irimia et al., 2018). However, the effect of an mTBI, which is the most frequent form of brain trauma, on the development of CMBs in aging, has not been established (Wang et al., 2014; Krishnamoorthy et al., 2015; Rauen et al., 2020). Here, we show (Figure 2) that significantly more microbleeds can be found in aging human brains than in the brains of young healthy individuals, confirming the results of previous studies (Greenberg et al., 2009; Werring et al., 2010; Toth et al., 2015; Akoudad et al., 2016; Wang et al., 2018). We also found significantly more CMBs in elderly patients after an mTBI compared with young patients with an mTBI; however, we did not observe a significant difference in the number of cerebral microhemorrhages between aged and aged patients with mTBIs. This suggests that aging and mTBIs do not synergize the induction of the development of CMBs.

The clinical consequences of CMBs, such as the development of cognitive decline, are most likely due to the cumulative effects of the lesions and the damage in specific anatomical locations (Werring et al., 2010; Ding et al., 2017; Ungvari et al., 2017). For example, damage to the fronto-subcortical circuits linking prefrontal areas to basal ganglia is associated with impairments in executive function, and the disarrangement of pathways from the mentioned areas projecting to the thalamus results in memory disturbances (Werring et al., 2010; Ding et al., 2017; Levit et al., 2020). Although morphological characteristics based on MRI examinations are not helpful in distinguishing CMBs of different etiologies, specific locations suggest the pathophysiological reasons of CMB formation (Greenberg et al., 2009; Wang et al., 2014; Yakushiji, 2015; Ding et al., 2017; Ungvari et al., 2017). For example, the typical brain areas for traumatic CMBs are the corona radiata and longitudinal fasciculus (Wang et al., 2014; Ungvari et al., 2017; Toth et al., 2020). Cerebral microbleeds in deep cerebral areas are thought to be due to cerebral angiopathy induced by hypertension, and lobar CMBs are likely due to amyloid angiopathy (Wang et al., 2014; Yakushiji, 2015; Ding et al., 2017; Ungvari et al., 2017). We found that aging alters the distribution of CMBs after an mTBI (Figure 2), namely, in elderly patients following an mTBI, the number of occipital and parietal bleedings was exacerbated compared with young patients. This may affect the functional consequences of these bleedings. Accordingly, the occipital and parietal lobes are responsible for integrating visual and cognitive information, and play an important role in voluntary coordination, posture and motor control, spatial cognition, and the rapid corrections of movements (Galletti et al., 2003; Niogi et al., 2008; Freedman and Ibos, 2018; MacKinnon, 2018). Specific tests should be part of the patient characterization after an mTBI to assess the region-specific consequences of CMBs in aging (and also in young patients), such as the trail making test, Beck’s depression test, and Montreal Cognitive Assessment test. This possibility should be verified in the future.

Limitations and Perspectives

The major limitations of this study are its retrospective design and relatively small sample size. Future prospective studies should verify the findings of this study with a large number of healthy control volunteers. We used the Mayo criteria to define an mTBI. Since other guidelines suggest slightly different scoring systems, it would be important to compare the CMB formation in TBI groups as defined by various scoring systems. Aging and mTBIs may interact in altering regulatory mechanisms of cerebral blood flow (CBF) in a functional manner. Accordingly, the changes in neurovascular coupling, autoregulation of CBF, and cerebrovascular reactivity should be assessed and correlated with the cognitive and gait functions in different age groups after mTBIs. Finally, the possible mechanisms through which aging and TBIs may interact to alter cerebrovascular function and the formation of CMBs should be studied, with a special focus on mitochondrial oxidative stress, the activation of redox-sensitive matrix metalloproteinases, the modification of the cerebrovascular wall, the production of proinflammatory cytokines, and the disruption of the blood-brain barrier (Lewén et al., 2001; Greenberg et al., 2009; Werring et al., 2010; de Laat et al., 2011; Toth et al., 2015, 2020; Yakushiji, 2015; Ungvari et al., 2018; Levit et al., 2020).

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics Statement

The studies involving human participants were reviewed and approved by the study was approved by the Regional Ethic Committee of the University of Pecs, Medical School, Hungary (7270-PTE 2018). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

LT and PT designed the studies and protocols. AC, PH, BK, and NS performed the literature search and collected the patient data. LT, AC, BK, and AT performed the image analysis. LT, AC, and NS generated the figures. LT, AC, and PT wrote the manuscript. LT, AC, PH, BK, NS, AT, AS, ZU, AB, and PT edited and revised the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by grants from the National Research, Development and Innovation Office to PT (NKFI-FK123798) and AB (K-134555), the Hungarian Academy of Sciences Bolyai Research Scholarship to PT, ÚNKP-20-3-II-PTE-493 New National Excellence Program of the Ministry for Innovation and Technology to PT and LT, EFOP-3.6.2.-16-2017-00008, GINOP-2.3.2-15-2016-00048, GINOP-2.2.1-15-2017-00067 to PT and AB, Hungarian Brain Research Program 2.0 Grant No. 2017-1.2.1-NKP-2017-00002 to AB, the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities to PT and AB, Thematic Excellence Program 2020-4.1.1-TKP2020 National Excellence Sub-program to LT, the National Institute of Health R01-AG055395, R01-NS100782, R01-AT006526 to ZU. This study was funded by the Hungarian Scientific Research Fund Grant No. OTKA/K-120356 to AS and AT.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

1. ^ http://www.slicer.org

References

Abdul-Muneer, P. M., Pfister, B. J., Haorah, J., and Chandra, N. (2016). Role of matrix metalloproteinases in the pathogenesis of traumatic brain injury. Mol. Neurobiol. 53, 6106–6123. doi: 10.1007/s12035-015-9520-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Akoudad, S., Wolters, F. J., Viswanathan, A., de Bruijn, R. F., van der Lugt, A., Hofman, A., et al. (2016). Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 73, 934–943. doi: 10.1001/jamaneurol.2016.1017

PubMed Abstract | CrossRef Full Text | Google Scholar

de Laat, K. F., van den Berg, H. A., van Norden, A. G., Gons, R. A., Olde Rikkert, M. G., and de Leeuw, F. E. (2011). Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease. Stroke 42, 494–497. doi: 10.1161/strokeaha.110.596122

PubMed Abstract | CrossRef Full Text | Google Scholar

Ding, J., Sigurðsson, S., Jónsson, P. V., Eiriksdottir, G., Meirelles, O., Kjartansson, O., et al. (2017). Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology 88, 2089–2097. doi: 10.1212/wnl.0000000000003983

PubMed Abstract | CrossRef Full Text | Google Scholar

Freedman, D. J., and Ibos, G. (2018). An integrative framework for sensory, motor, and cognitive functions of the posterior parietal cortex. Neuron 97, 1219–1234. doi: 10.1016/j.neuron.2018.01.044

PubMed Abstract | CrossRef Full Text | Google Scholar

Galletti, C., Kutz, D. F., Gamberini, M., Breveglieri, R., and Fattori, P. (2003). Role of the medial parieto-occipital cortex in the control of reaching and grasping movements. Exp. Brain Res. 153, 158–170. doi: 10.1007/s00221-003-1589-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Go, V., Bowley, B. G. E., Pessina, M. A., Zhang, Z. G., Chopp, M., Finklestein, S. P., et al. (2020). Extracellular vesicles from mesenchymal stem cells reduce microglial-mediated neuroinflammation after cortical injury in aged Rhesus monkeys. Geroscience 42, 1–17. doi: 10.1007/s11357-019-00115-w

PubMed Abstract | CrossRef Full Text | Google Scholar

Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., et al. (2009). Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 8, 165–174. doi: 10.1016/s1474-4422(09)70013-4

CrossRef Full Text | Google Scholar

Gregoire, S. M., Chaudhary, U. J., Brown, M. M., Yousry, T. A., Kallis, C., Jäger, H. R., et al. (2009). The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 73, 1759–1766. doi: 10.1212/WNL.0b013e3181c34a7d

PubMed Abstract | CrossRef Full Text | Google Scholar

Griffin, A. D., Turtzo, L. C., Parikh, G. Y., Tolpygo, A., Lodato, Z., Moses, A. D., et al. (2019). Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury. Brain 142, 3550–3564.

Google Scholar

Huang, Y. L., Kuo, Y. S., Tseng, Y. C., Chen, D. Y., Chiu, W. T., and Chen, C. J. (2015). Susceptibility-weighted MRI in mild traumatic brain injury. Neurology 84, 580–585. doi: 10.1212/wnl.0000000000001237

PubMed Abstract | CrossRef Full Text | Google Scholar

Irimia, A., Van Horn, J. D., and Vespa, P. M. (2018). Cerebral microhemorrhages due to traumatic brain injury and their effects on the aging human brain. Neurobiol. Aging 66, 158–164. doi: 10.1016/j.neurobiolaging.2018.02.026

PubMed Abstract | CrossRef Full Text | Google Scholar

Krishnamoorthy, V., Distelhorst, J. T., Vavilala, M. S., and Thompson, H. (2015). Traumatic brain injury in the elderly: burden, risk factors, and prevention. J. Trauma Nurs. 22, 204–208. doi: 10.1097/jtn.0000000000000135

PubMed Abstract | CrossRef Full Text | Google Scholar

Levit, A., Hachinski, V., and Whitehead, S. N. (2020). Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease. Geroscience 42, 445–465. doi: 10.1007/s11357-020-00164-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Lewén, A., Fujimura, M., Sugawara, T., Matz, P., Copin, J. C., and Chan, P. H. (2001). Oxidative stress-dependent release of mitochondrial cytochrome c after traumatic brain injury. J. Cereb. Blood Flow Metab. 21, 914–920. doi: 10.1097/00004647-200108000-00003

PubMed Abstract | CrossRef Full Text | Google Scholar

MacKinnon, C. D. (2018). Sensorimotor anatomy of gait, balance, and falls. Handb. Clin. Neurol. 159, 3–26. doi: 10.1016/b978-0-444-63916-5.00001-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Malec, J. F., Brown, A. W., Leibson, C. L., Flaada, J. T., Mandrekar, J. N., Diehl, N. N., et al. (2007). The mayo classification system for traumatic brain injury severity. J. Neurotrauma 24, 1417–1424. doi: 10.1089/neu.2006.0245

PubMed Abstract | CrossRef Full Text | Google Scholar

Niogi, S. N., Mukherjee, P., Ghajar, J., Johnson, C., Kolster, R. A., Sarkar, R., et al. (2008). Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: a 3T diffusion tensor imaging study of mild traumatic brain injury. AJNR Am. J. Neuroradiol. 29, 967–973. doi: 10.3174/ajnr.A0970

PubMed Abstract | CrossRef Full Text | Google Scholar

Nyúl-Tóth, Á, Tarantini, S., Kiss, T., Toth, P., Galvan, V., Tarantini, A., et al. (2020). Increases in hypertension-induced cerebral microhemorrhages exacerbate gait dysfunction in a mouse model of Alzheimer’s disease. Geroscience 42, 1685–1698. doi: 10.1007/s11357-020-00256-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Rachmany, L., Tweedie, D., Li, Y., Rubovitch, V., Holloway, H. W., Miller, J., et al. (2013). Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice. Age 35, 1621–1636. doi: 10.1007/s11357-012-9464-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Rauen, K., Späni, C. B., Tartaglia, M. C., Ferretti, M. T., Reichelt, L., Probst, P., et al. (2020). Quality of life after traumatic brain injury: a cross-sectional analysis uncovers age- and sex-related differences over the adult life span. Geroscience 43, 263–278. doi: 10.1007/s11357-020-00273-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Toth, A., Kovacs, N., Tamas, V., Kornyei, B., Nagy, M., Horvath, A., et al. (2016). Microbleeds may expand acutely after traumatic brain injury. Neurosci. Lett. 617, 207–212. doi: 10.1016/j.neulet.2016.02.028

PubMed Abstract | CrossRef Full Text | Google Scholar

Toth, L., Czigler, A., Horvath, P., Kornyei, B., Szarka, N., Schwarcz, A., et al. (2020). Traumatic brain injury-induced cerebral microbleeds in the elderly. Geroscience 43, 125–136. doi: 10.1007/s11357-020-00280-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Toth, P., Tarantini, S., Springo, Z., Tucsek, Z., Gautam, T., Giles, C. B., et al. (2015). Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection. Aging Cell 14, 400–408. doi: 10.1111/acel.12315

PubMed Abstract | CrossRef Full Text | Google Scholar

Ungvari, Z., Tarantini, S., Kirkpatrick, A. C., Csiszar, A., and Prodan, C. I. (2017). Cerebral microhemorrhages: mechanisms, consequences, and prevention. Am. J. Physiol. Heart Circ. Physiol. 312, H1128–H1143. doi: 10.1152/ajpheart.00780.2016

PubMed Abstract | CrossRef Full Text | Google Scholar

Ungvari, Z., Yabluchanskiy, A., Tarantini, S., Toth, P., Kirkpatrick, A. C., Csiszar, A., et al. (2018). Repeated Valsalva maneuvers promote symptomatic manifestations of cerebral microhemorrhages: implications for the pathogenesis of vascular cognitive impairment in older adults. Geroscience 40, 485–496. doi: 10.1007/s11357-018-0044-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, R., Liu, K., Ye, X., and Yan, S. (2018). Association between cerebral microbleeds and depression in the general elderly population: a meta-analysis. Front. Psychiatry 9:94. doi: 10.3389/fpsyt.2018.00094

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, X., Wei, X. E., Li, M. H., Li, W. B., Zhou, Y. J., Zhang, B., et al. (2014). Microbleeds on susceptibility-weighted MRI in depressive and non-depressive patients after mild traumatic brain injury. Neurol. Sci. 35, 1533–1539. doi: 10.1007/s10072-014-1788-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Werring, D. J., Gregoire, S. M., and Cipolotti, L. (2010). Cerebral microbleeds and vascular cognitive impairment. J. Neurol. Sci. 299, 131–135. doi: 10.1016/j.jns.2010.08.034

PubMed Abstract | CrossRef Full Text | Google Scholar

Yakushiji, Y. (2015). Cerebral microbleeds: detection, associations and clinical implications. Front. Neurol. Neurosci. 37:78–92. doi: 10.1159/000437115

PubMed Abstract | CrossRef Full Text | Google Scholar